This study plans to learn more about whether a support program delivered in Spanish or both English and Spanish for bilingual families helps Latino youth with Type 1 Diabetes (T1D) successfully use the Medtronic MiniMed 780G system.
The main question it aims to answer is:
Does a linguistically and culturally tailored onboarding model for an automated insulin delivery system close the gap in technology adoption and improve health outcomes?
Participants will:
* Use the Medtronic MiniMed 780G Automated Insulin Delivery system for eight months * Attend one in-person nutrition support and insulin pump start class * Participate in regular virtual check-ins with native Spanish-speaking study team members
Age 10 - 20 years old
Diagnosis of type 1 diabetes
Self-identify as Latino/Hispanic (determined via self-report and/or electronic health record)
Currently managing diabetes using any regimen, including multiple daily injections (MDI) or any non-Medtronic automated insulin delivery system
Current use of any Medtronic technology
More than 1 episode of diabetic ketoacidosis (DKA) within 12 months of study enrollment
Current pregnancy (self-reported), due to limited safety data for use of the Medtronic MiniMed 780G system during pregnancy
Presence of any significant medical condition that, in the opinion of the investigator, would interfere with study participation or data interpretation
University of Colorado, Denver
Lead sponsor
Barbara Davis Center of Childhood Diabetes, University of Co
Collaborator